Color Vision Defects: Clinical Trials

3 trials for Color Vision Defects, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 recruiting, 1 terminated. 3 Phase 3, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 33Recruiting 2, Terminated 1
Phase 21Recruiting 1

Follow Color Vision Defects: new trials by email Literature Review of Color Vision Defects trials Research Report on Color Vision Defects

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Paclitaxel Coated Balloon for the Treatment of Chronic bEnigN sTricture- Bowel
GIE Medical ProTractX3 TTS DCB, Control - Bowel; Stricture
Phase 3RecruitingGIE Medical1712023-11-012025-06-25
Alcohol Use Disorder and Cannabidiol
Cannabidiol, Placebo - Alcohol Use Disorder
Phase 2 / Phase 3RecruitingUniversity of Colorado, Denver1802023-04-302026-06-15
Cannabis Extract in Refractory Epilepsy Study
Medical Cannabis, Placebo - Drug Resistant Epilepsy
Phase 3TerminatedThe Epilepsy Research Program of the Ontario Brain Institute172019-01-102020-09-11

Narrower conditions

Marijuana Abuse (2)  ·  Alcoholism (1)  ·  Constriction, Pathologic (1)  ·  Drug Resistant Epilepsy (1)  ·  Epilepsy (1)  ·  Seizures (1)

Broader conditions

Cone Dystrophy (3)  ·  Eye Diseases (3)  ·  Eye Diseases, Hereditary (3)  ·  Nervous System Diseases (3)  ·  Neurologic Manifestations (3)  ·  Pathological Conditions, Signs and Symptoms (3)  ·  Sensation Disorders (3)  ·  Signs and Symptoms (3)  ·  Vision Disorders (3)  ·  Chemically-Induced Disorders (2)  ·  Mental Disorders (2)  ·  Substance-Related Disorders (2)  ·  Alcohol-Related Disorders (1)  ·  Brain Diseases (1)  ·  Central Nervous System Diseases (1)

Interventions

Cannabidiol (1)  ·  Medical Marijuana (1)

Sponsors

GIE Medical (1)  ·  The Epilepsy Research Program of the Ontario Brain Institute (1)  ·  University of Colorado, Denver (1)

Countries

United States (2)  ·  Canada (1)

Top investigators

Danielle Andrade, MD (1)  ·  Kent Hutchison, PhD (1)  ·  Nancy Mingo, MD (1)  ·  Peter Tai, MD (1)  ·  Seyed Mirsattari, MD (1)  ·  W M Burnham, PhD (1)

NIH funding

R01AA029606 (1)